The US National Institutes of Health has created the COVID-19 Neuro Databank/Biobank (NeuroCOVID), a database to enable recording and tracking of neurological involvement in COVID-19. Health-care providers in the USA can submit anonymized information online about neurological symptoms, comorbidities, disease course, complications, sequelae and outcomes of patients with COVID-19. Biospecimens collected for research or clinical management can also be provided to the biobank.
References
Original article
National Institutes of Health. NIH launches database to track neurological symptoms associated with COVID-19. NIH https://www.nih.gov/news-events/news-releases/nih-launches-database-track-neurological-symptoms-associated-covid-19 (2021)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fyfe, I. COVID-19 database launched in the USA. Nat Rev Neurol 17, 132 (2021). https://doi.org/10.1038/s41582-021-00468-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-021-00468-x